Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
202,864,332
-
Share change
-
-4,319,370
-
Total reported value
-
$17,249,894,434
-
Put/Call ratio
-
83%
-
Price per share
-
$85.03
-
Number of holders
-
408
-
Value change
-
+$350,642,519
-
Number of buys
-
237
-
Number of sells
-
194
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q3 2020
As of 30 Sep 2020,
IMMUNOMEDICS INC - COM (IMMU) was held by
408 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
202,864,332 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., HBK INVESTMENTS L P, FARALLON CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Palo Alto Investors LP, BOXER CAPITAL, LLC, RP Management, LLC, and Pentwater Capital Management LP.
This page lists
408
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.